Stocks and Investing
Stocks and Investing
Wed, March 11, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Laura Chico Upgraded (APLS) to Hold and Held Target at $29 on, Mar 11th, 2020
Laura Chico of Wedbush, Upgraded "Apellis Pharmaceuticals, Inc." (APLS) to Hold and Held Target at $29 on, Mar 11th, 2020.
Laura has made no other calls on APLS in the last 4 months.
There are 3 other peers that have a rating on APLS. Out of the 3 peers that are also analyzing APLS, 1 agrees with Laura's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Tiago Fauth of "Credit Suisse" Maintained at Hold with Decreased Target to $34 on, Monday, March 2nd, 2020
These are the ratings of the 2 analyists that currently disagree with Laura
- Brian Cheng of "B of A Securities" Initiated at Strong Buy and Held Target at $36 on, Thursday, December 19th, 2019
- Eliana Merle of "Cantor Fitzgerald" Reiterated at Buy with Increased Target to $54 on, Monday, November 25th, 2019